News: Zepbound (tirzepatide) Approved to Treat Obstructive Sleep Apnea

The weight-loss drug Zepbound is the first FDA-approved prescription medicine to help treat obstructive sleep apnea (OSA). Zepbound, or tirzepatide, originally received approval in November 2023 to treat obesity. It’s now a new rival to Novo Nordisk’s popular drug, Wegovy. The FDA has now given the green light for tirzepatide to treat obstructive sleep apnea […]
Natural GLP-1 Supplements: Do They Match Wegovy’s Power?

With the rising popularity of weight-loss drugs, some wellness companies are promoting supplements that they claim can boost the levels of natural GLP-1 that can control hunger and promote weight loss. These products target people who are looking for a weight loss solution that isn’t as expensive as GLP-1 injections, which in most cases are […]
Using Nutrition to Offset GLP-1 Side Effects

Glucagon-like peptide-1 (GLP-1) drugs like Ozempic and Wegovy are among the latest innovations in diabetes and weight management. However, they do come with some commonly experienced side effects for users. Happily, I can advise about some nutritional changes that can work to reduce these side effects while also enhancing the efficacy of the medications. GLP-1 […]
IsraelPharm’s Top 10 Bestselling Medications: Do You Take Any of Them?

If you’re wondering which are the most popular products sold on the IsraelPharm website, we’re here to tell you! Let’s take a look at our bestselling medications. GLP-1 group of drugs Since the release of Ozempic in 2017, there has been a tremendous surge in the use of GLP-1-based medicines for treating a wide variety […]
GLP-1 Agonists: A Potential Game-Changer for Addictive Behavior

A complicated research paper was published just a few weeks ago on the Nature website that introduces some exciting new findings about how GLP-1 agonist medications like semaglutide, Ozempic, Mounjaro, Wegovy, and trizepatide may be capable of doing far more than just treating diabetes and obesity. One of the most impressive findings indicates that addictive […]
The Gila monster gave the weight-loss revolution its bite

It’s currently estimated that over one-half of the adult US population is either overweight or obese. Being overweight means having a Body Mass Index (BMI) between 25 and 30. Obese means a BMI higher than 30. This statistic shouldn’t be taken to indicate neglect by the healthcare, research, or pharmaceutical industry. In reality, enormous attention […]
Treating Obstructive Sleep Apnea with Tirzepatide

Interrupted breathing during sleep, technically known as Obstructive Sleep Apnea (OSA), is a fairly common problem that has, until now, been difficult to address with pharmaceutical treatment. OSA has one quite special characteristic, in that people living with the condition often don’t know that they have it because it occurs only when they are sound […]
What You Need to Know About Wegovy for Weight Loss

Wegovy and Zepbound, the latest forms of GLP-1 receptor agonist weight-loss medications, have generated a flood of media and public attention thanks to the effectiveness of weight management, which promotes rapid and sustainable weight and waistline reductions. Since we added them to our range of medications, we have received a lot of positive feedback from […]
Medicare now approves weight-loss drugs for people with heart problems

There has been much attention in the media to an announcement from Medicare in mid-March 2024. In essence, it said that it has now agreed to start paying for one of the leading weight-loss drugs for people with heart problems when it is prescribed to treat overweight or obese patients if they are at risk […]
Can Metformin be used for more than just diabetes?

Metformin has a long history as a substance with some medical value. It dates back even before its official recognition in 1918 for its ability to reduce blood sugar levels. Before any medical knowledge about diabetes, herbalists utilized a plant called Galega officinalis (also known as goat’s rue or French Lilac) to treat people who […]


